Disease-specific glycosaminoglycan patterns in the extracellular matrix of human lung and brain

Carbohydr Res. 2022 Jan:511:108480. doi: 10.1016/j.carres.2021.108480. Epub 2021 Nov 17.

Abstract

A wide variety of diseases throughout the mammalian organism is characterized by abnormal deposition of various components of the extracellular matrix (ECM), including the heterogeneous family of glycosaminoglycans (GAGs), which contribute considerably to the ECM architecture as part of the so-called proteoglycans. The GAG's unique sulfation pattern, derived from highly dynamic and specific modification processes, has a massive impact on critical mediators such as cytokines and growth factors. Due to the strong connection between the specific sulfation pattern and GAG function, slight alterations of this pattern are often associated with enormous changes at the cell as well as at the organ level. This review aims to investigate the connection between modifications of GAG sulfation patterns and the wide range of pathological conditions, mainly focusing on a range of chronic diseases of the central nervous system (CNS) as well as the respiratory tract.

Keywords: Chondroitin sulfate; Dermatan sulfate; ECM remodeling; Glycosaminoglycans; Glycosaminoglycans in disease; Heparan sulfate; Keratan sulfate; Proteoglycans.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / metabolism
  • Chondroitin Sulfates / metabolism
  • Extracellular Matrix* / metabolism
  • Glycosaminoglycans* / metabolism
  • Humans
  • Lung
  • Mammals / metabolism
  • Proteoglycans

Substances

  • Glycosaminoglycans
  • Proteoglycans
  • Chondroitin Sulfates